APO Research
Talk to an analyst

APO RESEARCH · REPORT

Clotting Factors Ⅷ

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Clotting Factors Ⅷ Industry Growth and Trends Forecast to 2032

23 December 202574 pages

Choose your research edition.

Industry ResearchClotting Factors Ⅷ Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Clotting Factors Ⅷ Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Clotting Factors Ⅷ Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Clotting Factors Ⅷ Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Clotting Factors Ⅷ Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Clotting Factors Ⅷ market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Clotting Factors Ⅷ is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Clotting Factors Ⅷ is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Clotting Factors Ⅷ is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Clotting Factors Ⅷ include Taibang Biological, Shanghai Laishi, Lvshizi and Hualan Biological, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Clotting Factors Ⅷ market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Clotting Factors Ⅷ market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Clotting Factors Ⅷ market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Clotting Factors Ⅷ.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Clotting Factors Ⅷ market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Clotting Factors Ⅷ Market by Company

Taibang Biological

Shanghai Laishi

Lvshizi

Hualan Biological

Clotting Factors Ⅷ Segment by Type

Injection

Freeze-dried Injection

Clotting Factors Ⅷ Segment by Application

Hemophilia A

Bleeding Diseases

Clotting Factors Ⅷ Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clotting Factors Ⅷ market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Clotting Factors Ⅷ and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clotting Factors Ⅷ.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Clotting Factors Ⅷ manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Clotting Factors Ⅷ in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Freeze-dried Injection Table 3. Global Clotting Factors Ⅷ Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Clotting Factors Ⅷ Sales by Type (2021-2026) & (k units) Table 5. Global Clotting Factors Ⅷ Sales Market Share in Volume by Type (2021-2026) Table 6. Global Clotting Factors Ⅷ Sales by Type (2021-2026) & (US$ Million) Table 7. Global Clotting Factors Ⅷ Sales Market Share in Value by Type (2021-2026) Table 8. Global Clotting Factors Ⅷ Price by Type (2021-2026) & (US$/unit) Table 9. Global Clotting Factors Ⅷ Sales by Type (2027-2032) & (k units) Table 10. Global Clotting Factors Ⅷ Sales Market Share in Volume by Type (2027-2032) Table 11. Global Clotting Factors Ⅷ Sales by Type (2027-2032) & (US$ Million) Table 12. Global Clotting Factors Ⅷ Sales Market Share in Value by Type (2027-2032) Table 13. Global Clotting Factors Ⅷ Price by Type (2027-2032) & (US$/unit) Table 14. North America Clotting Factors Ⅷ Sales by Type (2021-2026) & (k units) Table 15. North America Clotting Factors Ⅷ Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Clotting Factors Ⅷ Sales by Type (2021-2026) & (k units) Table 17. Europe Clotting Factors Ⅷ Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Clotting Factors Ⅷ Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Clotting Factors Ⅷ Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Clotting Factors Ⅷ Sales by Type (2021-2026) & (k units) Table 21. Latin America Clotting Factors Ⅷ Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Clotting Factors Ⅷ Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Clotting Factors Ⅷ Sales by Type (2021-2026) & (US$ Million) Table 24. Clotting Factors Ⅷ Industry Trends Table 25. Clotting Factors Ⅷ Industry Drivers Table 26. Clotting Factors Ⅷ Industry Opportunities and Challenges Table 27. Clotting Factors Ⅷ Industry Restraints Table 28. Global Clotting Factors Ⅷ Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Clotting Factors Ⅷ Revenue Market Share by Company (2021-2026) Table 30. Global Clotting Factors Ⅷ Sales by Company (2021-2026) & (k units) Table 31. Global Clotting Factors Ⅷ Sales Share by Company (2021-2026) Table 32. Global Clotting Factors Ⅷ Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Clotting Factors Ⅷ Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Clotting Factors Ⅷ Major Company Production Sites and Headquarters Table 35. Global Clotting Factors Ⅷ Company, Product Type & Application Table 36. Global Clotting Factors Ⅷ Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Clotting Factors Ⅷ by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Clotting Factors Ⅷ Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Clotting Factors Ⅷ Sales by Region (2021-2026) & (k units) Table 41. Global Clotting Factors Ⅷ Sales Market Share in Volume by Region (2021-2026) Table 42. Global Clotting Factors Ⅷ Sales by Region (2021-2026) & (US$ Million) Table 43. Global Clotting Factors Ⅷ Sales Market Share in Value by Region (2021-2026) Table 44. Global Clotting Factors Ⅷ Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Clotting Factors Ⅷ Sales by Region (2027-2032) & (k units) Table 46. Global Clotting Factors Ⅷ Sales Market Share in Volume by Region (2027-2032) Table 47. Global Clotting Factors Ⅷ Sales by Region (2027-2032) & (US$ Million) Table 48. Global Clotting Factors Ⅷ Sales Market Share in Value by Region (2027-2032) Table 49. Global Clotting Factors Ⅷ Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Clotting Factors Ⅷ Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Clotting Factors Ⅷ Sales by Application (2021-2026) & (k units) Table 52. Global Clotting Factors Ⅷ Sales Market Share in Volume by Application (2021-2026) Table 53. Global Clotting Factors Ⅷ Sales by Application (2021-2026) & (US$ Million) Table 54. Global Clotting Factors Ⅷ Sales Market Share in Value by Application (2021-2026) Table 55. Global Clotting Factors Ⅷ Price by Application (2021-2026) & (US$/unit) Table 56. Global Clotting Factors Ⅷ Sales by Application (2027-2032) & (k units) Table 57. Global Clotting Factors Ⅷ Sales Market Share in Volume by Application (2027-2032) Table 58. Global Clotting Factors Ⅷ Sales by Application (2027-2032) & (US$ Million) Table 59. Global Clotting Factors Ⅷ Sales Market Share in Value by Application (2027-2032) Table 60. Global Clotting Factors Ⅷ Price by Application (2027-2032) & (US$/unit) Table 61. North America Clotting Factors Ⅷ Sales by Application (2021-2026) & (k units) Table 62. North America Clotting Factors Ⅷ Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Clotting Factors Ⅷ Sales by Application (2021-2026) & (k units) Table 64. Europe Clotting Factors Ⅷ Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Clotting Factors Ⅷ Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Clotting Factors Ⅷ Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Clotting Factors Ⅷ Sales by Application (2021-2026) & (k units) Table 68. Latin America Clotting Factors Ⅷ Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Clotting Factors Ⅷ Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Clotting Factors Ⅷ Sales by Application (2021-2026) & (US$ Million) Table 71. Taibang Biological Company Information Table 72. Taibang Biological Business Overview Table 73. Taibang Biological Clotting Factors Ⅷ Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Taibang Biological Clotting Factors Ⅷ Product Portfolio Table 75. Taibang Biological Recent Development Table 76. Shanghai Laishi Company Information Table 77. Shanghai Laishi Business Overview Table 78. Shanghai Laishi Clotting Factors Ⅷ Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Shanghai Laishi Clotting Factors Ⅷ Product Portfolio Table 80. Shanghai Laishi Recent Development Table 81. Lvshizi Company Information Table 82. Lvshizi Business Overview Table 83. Lvshizi Clotting Factors Ⅷ Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Lvshizi Clotting Factors Ⅷ Product Portfolio Table 85. Lvshizi Recent Development Table 86. Hualan Biological Company Information Table 87. Hualan Biological Business Overview Table 88. Hualan Biological Clotting Factors Ⅷ Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Hualan Biological Clotting Factors Ⅷ Product Portfolio Table 90. Hualan Biological Recent Development Table 91. North America Clotting Factors Ⅷ Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 92. North America Clotting Factors Ⅷ Sales by Country (2021-2026) & (k units) Table 93. North America Clotting Factors Ⅷ Sales Market Share by Country (2021-2026) Table 94. North America Clotting Factors Ⅷ Sales Forecast by Country (2027-2032) & (k units) Table 95. North America Clotting Factors Ⅷ Sales Market Share Forecast by Country (2027-2032) Table 96. North America Clotting Factors Ⅷ Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Clotting Factors Ⅷ Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Clotting Factors Ⅷ Market Share by Country (2021-2026) Table 99. North America Clotting Factors Ⅷ Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Clotting Factors Ⅷ Market Share Forecast by Country (2027-2032) Table 101. Europe Clotting Factors Ⅷ Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 102. Europe Clotting Factors Ⅷ Sales by Country (2021-2026) & (k units) Table 103. Europe Clotting Factors Ⅷ Sales Market Share by Country (2021-2026) Table 104. Europe Clotting Factors Ⅷ Sales Forecast by Country (2027-2032) & (k units) Table 105. Europe Clotting Factors Ⅷ Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Clotting Factors Ⅷ Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Clotting Factors Ⅷ Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Clotting Factors Ⅷ Market Share by Country (2021-2026) Table 109. Europe Clotting Factors Ⅷ Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Clotting Factors Ⅷ Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Clotting Factors Ⅷ Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Clotting Factors Ⅷ Sales by Country (2021-2026) & (k units) Table 113. Asia-Pacific Clotting Factors Ⅷ Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Clotting Factors Ⅷ Sales Forecast by Country (2027-2032) & (k units) Table 115. Asia-Pacific Clotting Factors Ⅷ Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Clotting Factors Ⅷ Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Clotting Factors Ⅷ Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Clotting Factors Ⅷ Market Share by Country (2021-2026) Table 119. Asia-Pacific Clotting Factors Ⅷ Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Clotting Factors Ⅷ Market Share Forecast by Country (2027-2032) Table 121. Latin America Clotting Factors Ⅷ Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. Latin America Clotting Factors Ⅷ Sales by Country (2021-2026) & (k units) Table 123. Latin America Clotting Factors Ⅷ Sales Market Share by Country (2021-2026) Table 124. Latin America Clotting Factors Ⅷ Sales Forecast by Country (2027-2032) & (k units) Table 125. Latin America Clotting Factors Ⅷ Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Clotting Factors Ⅷ Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Clotting Factors Ⅷ Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Clotting Factors Ⅷ Market Share by Country (2021-2026) Table 129. Latin America Clotting Factors Ⅷ Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Clotting Factors Ⅷ Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Clotting Factors Ⅷ Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Clotting Factors Ⅷ Sales by Country (2021-2026) & (k units) Table 133. Middle East and Africa Clotting Factors Ⅷ Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Clotting Factors Ⅷ Sales Forecast by Country (2027-2032) & (k units) Table 135. Middle East and Africa Clotting Factors Ⅷ Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Clotting Factors Ⅷ Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Clotting Factors Ⅷ Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Clotting Factors Ⅷ Market Share by Country (2021-2026) Table 139. Middle East and Africa Clotting Factors Ⅷ Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Clotting Factors Ⅷ Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Clotting Factors Ⅷ Distributors List Table 144. Clotting Factors Ⅷ Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Clotting Factors Ⅷ Image Figure 2. Global Clotting Factors Ⅷ Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Clotting Factors Ⅷ Market Size (2021-2032) & (US$ Million) Figure 4. Global Clotting Factors Ⅷ Sales (2021-2032) & (k units) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (k units) Figure 7. Freeze-dried Injection Image Figure 8. Global Freeze-dried Injection Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Clotting Factors Ⅷ Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Clotting Factors Ⅷ Market Share by Type 2025 VS 2032 Figure 11. North America Clotting Factors Ⅷ Sales Market Share in Volume by Type in 2025 Figure 12. North America Clotting Factors Ⅷ Sales Market Share in Value by Type in 2025 Figure 13. Europe Clotting Factors Ⅷ Sales Market Share in Volume by Type in 2025 Figure 14. Europe Clotting Factors Ⅷ Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Clotting Factors Ⅷ Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Clotting Factors Ⅷ Sales Market Share in Value by Type in 2025 Figure 17. Latin America Clotting Factors Ⅷ Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Clotting Factors Ⅷ Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Clotting Factors Ⅷ Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Clotting Factors Ⅷ Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Clotting Factors Ⅷ Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hemophilia A Image Figure 24. Global Hemophilia A Sales YoY Growth (2021-2032) & (k units) Figure 25. Bleeding Diseases Image Figure 26. Global Bleeding Diseases Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Clotting Factors Ⅷ Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Clotting Factors Ⅷ Market Share by Application 2025 VS 2032 Figure 29. North America Clotting Factors Ⅷ Sales Market Share in Volume by Application in 2025 Figure 30. North America Clotting Factors Ⅷ Sales Market Share in Value by Application in 2025 Figure 31. Europe Clotting Factors Ⅷ Sales Market Share in Volume by Application in 2025 Figure 32. Europe Clotting Factors Ⅷ Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Clotting Factors Ⅷ Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Clotting Factors Ⅷ Sales Market Share in Value by Application in 2025 Figure 35. Latin America Clotting Factors Ⅷ Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Clotting Factors Ⅷ Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Clotting Factors Ⅷ Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Clotting Factors Ⅷ Sales Market Share in Value by Application in 2025 Figure 39. North America Clotting Factors Ⅷ Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Clotting Factors Ⅷ Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Clotting Factors Ⅷ Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Clotting Factors Ⅷ Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Clotting Factors Ⅷ Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Clotting Factors Ⅷ Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Clotting Factors Ⅷ Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Clotting Factors Ⅷ Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Clotting Factors Ⅷ Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Clotting Factors Ⅷ Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Clotting Factors Ⅷ Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Clotting Factors Ⅷ Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Clotting Factors Ⅷ Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Clotting Factors Ⅷ Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Clotting Factors Ⅷ Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Clotting Factors Ⅷ Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Clotting Factors Ⅷ Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Clotting Factors Ⅷ Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Clotting Factors Ⅷ Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Clotting Factors Ⅷ Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Clotting Factors Ⅷ Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Clotting Factors Ⅷ Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Freeze-dried Injection
Applications
  • Hemophilia A
  • Bleeding Diseases
Companies covered
  • Taibang Biological
  • Shanghai Laishi
  • Lvshizi
  • Hualan Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Clotting Factors Ⅷ Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Clotting Factors Ⅷ Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Clotting Factors Ⅷ Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Freeze-dried Injection
  8. 1.4 Global Clotting Factors Ⅷ Market Size by Type
  9. 1.4.1 Global Clotting Factors Ⅷ Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Clotting Factors Ⅷ Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Clotting Factors Ⅷ Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Clotting Factors Ⅷ Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Clotting Factors Ⅷ Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Clotting Factors Ⅷ Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Clotting Factors Ⅷ Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Clotting Factors Ⅷ Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Clotting Factors Ⅷ Industry Trends
  2. 2.2 Clotting Factors Ⅷ Industry Drivers
  3. 2.3 Clotting Factors Ⅷ Industry Opportunities and Challenges
  4. 2.4 Clotting Factors Ⅷ Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Clotting Factors Ⅷ Revenue (2021-2026)
  2. 3.2 Global Top Players by Clotting Factors Ⅷ Sales (2021-2026)
  3. 3.3 Global Top Players by Clotting Factors Ⅷ Price (2021-2026)
  4. 3.4 Global Clotting Factors Ⅷ Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Clotting Factors Ⅷ Major Company Production Sites & Headquarters
  6. 3.6 Global Clotting Factors Ⅷ Company, Product Type & Application
  7. 3.7 Global Clotting Factors Ⅷ Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Clotting Factors Ⅷ Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Clotting Factors Ⅷ Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Clotting Factors Ⅷ Tier 1, Tier 2, and Tier 3
4 Clotting Factors Ⅷ Regional Status and Outlook
  1. 4.1 Global Clotting Factors Ⅷ Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Clotting Factors Ⅷ Historic Market Size by Region
  3. 4.2.1 Global Clotting Factors Ⅷ Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Clotting Factors Ⅷ Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Clotting Factors Ⅷ Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Clotting Factors Ⅷ Forecasted Market Size by Region
  7. 4.3.1 Global Clotting Factors Ⅷ Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Clotting Factors Ⅷ Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Clotting Factors Ⅷ Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Clotting Factors Ⅷ by Application
  1. 5.1 Clotting Factors Ⅷ Market by Application
  2. 5.1.1 Hemophilia A
  3. 5.1.2 Bleeding Diseases
  4. 5.2 Global Clotting Factors Ⅷ Market Size by Application
  5. 5.2.1 Global Clotting Factors Ⅷ Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Clotting Factors Ⅷ Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Clotting Factors Ⅷ Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Clotting Factors Ⅷ Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Clotting Factors Ⅷ Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Clotting Factors Ⅷ Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Clotting Factors Ⅷ Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Clotting Factors Ⅷ Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Taibang Biological
  2. 6.1.1 Taibang Biological Company Information
  3. 6.1.2 Taibang Biological Business Overview
  4. 6.1.3 Taibang Biological Clotting Factors Ⅷ Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Taibang Biological Clotting Factors Ⅷ Product Portfolio
  6. 6.1.5 Taibang Biological Recent Developments
  7. 6.2 Shanghai Laishi
  8. 6.2.1 Shanghai Laishi Company Information
  9. 6.2.2 Shanghai Laishi Business Overview
  10. 6.2.3 Shanghai Laishi Clotting Factors Ⅷ Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shanghai Laishi Clotting Factors Ⅷ Product Portfolio
  12. 6.2.5 Shanghai Laishi Recent Developments
  13. 6.3 Lvshizi
  14. 6.3.1 Lvshizi Company Information
  15. 6.3.2 Lvshizi Business Overview
  16. 6.3.3 Lvshizi Clotting Factors Ⅷ Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Lvshizi Clotting Factors Ⅷ Product Portfolio
  18. 6.3.5 Lvshizi Recent Developments
  19. 6.4 Hualan Biological
  20. 6.4.1 Hualan Biological Company Information
  21. 6.4.2 Hualan Biological Business Overview
  22. 6.4.3 Hualan Biological Clotting Factors Ⅷ Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hualan Biological Clotting Factors Ⅷ Product Portfolio
  24. 6.4.5 Hualan Biological Recent Developments
7 North America by Country
  1. 7.1 North America Clotting Factors Ⅷ Sales by Country
  2. 7.1.1 North America Clotting Factors Ⅷ Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Clotting Factors Ⅷ Sales by Country (2021-2026)
  4. 7.1.3 North America Clotting Factors Ⅷ Sales Forecast by Country (2027-2032)
  5. 7.2 North America Clotting Factors Ⅷ Market Size by Country
  6. 7.2.1 North America Clotting Factors Ⅷ Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Clotting Factors Ⅷ Market Size by Country (2021-2026)
  8. 7.2.3 North America Clotting Factors Ⅷ Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Clotting Factors Ⅷ Sales by Country
  2. 8.1.1 Europe Clotting Factors Ⅷ Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Clotting Factors Ⅷ Sales by Country (2021-2026)
  4. 8.1.3 Europe Clotting Factors Ⅷ Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Clotting Factors Ⅷ Market Size by Country
  6. 8.2.1 Europe Clotting Factors Ⅷ Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Clotting Factors Ⅷ Market Size by Country (2021-2026)
  8. 8.2.3 Europe Clotting Factors Ⅷ Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Clotting Factors Ⅷ Sales by Country
  2. 9.1.1 Asia-Pacific Clotting Factors Ⅷ Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Clotting Factors Ⅷ Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Clotting Factors Ⅷ Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Clotting Factors Ⅷ Market Size by Country
  6. 9.2.1 Asia-Pacific Clotting Factors Ⅷ Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Clotting Factors Ⅷ Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Clotting Factors Ⅷ Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Clotting Factors Ⅷ Sales by Country
  2. 10.1.1 South America Clotting Factors Ⅷ Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Clotting Factors Ⅷ Sales by Country (2021-2026)
  4. 10.1.3 South America Clotting Factors Ⅷ Sales Forecast by Country (2027-2032)
  5. 10.2 South America Clotting Factors Ⅷ Market Size by Country
  6. 10.2.1 South America Clotting Factors Ⅷ Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Clotting Factors Ⅷ Market Size by Country (2021-2026)
  8. 10.2.3 South America Clotting Factors Ⅷ Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Clotting Factors Ⅷ Sales by Country
  2. 11.1.1 Middle East and Africa Clotting Factors Ⅷ Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Clotting Factors Ⅷ Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Clotting Factors Ⅷ Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Clotting Factors Ⅷ Market Size by Country
  6. 11.2.1 Middle East and Africa Clotting Factors Ⅷ Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Clotting Factors Ⅷ Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Clotting Factors Ⅷ Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Clotting Factors Ⅷ Value Chain Analysis
  2. 12.1.1 Clotting Factors Ⅷ Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Clotting Factors Ⅷ Production Mode & Process
  7. 12.2 Clotting Factors Ⅷ Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Clotting Factors Ⅷ Distributors
  10. 12.2.3 Clotting Factors Ⅷ Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst